
Clinical trials over the last 15 years have demonstrated that cell and gene therapies for cancer, zzso and infectious disease are feasible and can lead to long-term benefit for zzso However, these trials have been limited to zzso and were conducted on modest numbers of patients or over long periods of zzso In order for these studies to move towards standard practice and zzso zzso technologies for the isolation, ex zzso manipulation and delivery of these cells to patients must be zzso Additionally, regulatory strategies and clinical protocols for the collection, creation and delivery of cell products must be zzso In this article we review recent progress in zzso cell and gene therapy, describe some of the current issues facing the field and discuss clinical, technical and regulatory approaches used to navigate the road to product zzso 

